Sunday, November 13, 2016
- 9:00AM-11:00AM
-
Abstract Number: 792
Systemic Lupus Erythematosus (SLE) Responder Index [SRI(4)] Response Is Associated with Global Benefit in Patients with Moderate to Severe SLE
Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster I: Clinical Trial Design and Current Therapies- 9:00AM-11:00AM
-
Abstract Number: 50
Tai Chi Significantly Modulates Resting State Functional Connectivity of the Cognitive Control Network in Fibromyalgia
Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes - Poster I: Basic Science Focus- 9:00AM-11:00AM
-
Abstract Number: 864
Takayasu Arteritis Developed over the Age of 40 Has Lower Levels of Interferon Gamma and Interleukin 17 at Disease Onset and Fewer Subsequent Relapses
Vasculitis - Poster I: Large Vessel Vasculitis and Polymyalgia Rheumatica- 9:00AM-11:00AM
-
Abstract Number: 852
Targeting Fibroblastoid-like Cells By Drug Loaded Engineered Gold Nanoparticles As a Novel Approach for ILD-SSc Treatment
Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster I- 9:00AM-11:00AM
-
Abstract Number: 674
Targeting Glandular IL-21-Production in Primary Sjogren′s Syndrome Patients By Immunomodulatory Treatment
Sjögren's Syndrome - Poster I: Translational Science- 9:00AM-11:00AM
-
Abstract Number: 484
Targeting the BTK-JAK Axis in Preclinical Models of Rat Collagen-Induced Arthritis with GS-4059 in Combination with a JAK Inhibitor
Rheumatoid Arthritis – Animal Models - Poster I- 9:00AM-11:00AM
-
Abstract Number: 460
TAS5315, a Novel Bruton’s Tyrosine Kinase Inhibitor, Demonstrates Anti-Inflammatory Effect in Autoimmune Disease Models
Rheumatoid Arthritis – Animal Models - Poster I- 9:00AM-11:00AM
-
Abstract Number: 577
TCZ Modulates the Production of Ccfdna Derived from RA Synovial Cells
Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster I- 9:00AM-11:00AM
-
Abstract Number: 439
Temple University Hospital Rheumatology Narcotic Contract
Quality Measures and Quality of Care - Poster I- 9:00AM-11:00AM
-
Abstract Number: 903
Temporal Arteritis: Is There Any Correlation Between Ultrasonographic Arterial Wall Involvement and the Inflammatory Cellular Infiltrate at Histological Examination?
Vasculitis - Poster I: Large Vessel Vasculitis and Polymyalgia Rheumatica- 9:00AM-11:00AM
-
Abstract Number: 867
Termination of Tocilizumab-Treatment in Giant Cell Arteritis: Follow-up of Patients after the RCT (ClinicalTrials.gov registration number: NCT01450137)
Vasculitis - Poster I: Large Vessel Vasculitis and Polymyalgia Rheumatica- 9:00AM-11:00AM
-
Abstract Number: 493
The 2010 ACR/EULAR Criteria Are Not Sufficiently Accurate in the Early Identification of Autoantibody-Negative Rheumatoid Arthritis
Rheumatoid Arthritis – Clinical Aspects - Poster I: Clinical Characteristics/Presentation/Prognosis- 9:00AM-11:00AM
-
Abstract Number: 102
The 2015 American College of Rheumatology (ACR) Workforce Study: A Snapshot of Academic Division Directors
Health Services Research - Poster I- 9:00AM-11:00AM
-
Abstract Number: 136
The 7-Joints Musculoskeletal Ultrasound Score (US7 score) Predicts Therapeutic Change in Patients with Early Rheumatoid Arthritis